Project Manager (Oncology)

ICON plc is a global healthcare intelligence and clinical research organisation focused on bringing new medicines and treatments to patients faster. The Clinical Project Manager will oversee oncology clinical projects or portfolios, serve as the primary client liaison, manage deliverables, timelines, finances, risks, vendors, and cross-functional teams, and provide performance feedback.

Responsibilities:

• Act as primary liaison with clients
• Lead and direct cross-functional team leaders and third parties/vendors with some supervision and support
• Manage project contractual deliverables, including progress via metrics and adherence to contractual agreement time, quality/scope, and cost deliverables)
• Participation and attendance in bid defense process
• Provide feedback on project team members’ performance to respective line-managers
• Maintain detailed understanding of each functional service area and lead multifaceted functional teams effectively with little supervision or support
• Develop in depth analysis and projections of project timelines and financials for senior and customer management with little to no supervision

Requirements:

• • Minimum of 3 years' experience in clinical research within a CRO
• • Undergraduate degree or its international equivalent from an accredited institution or an equivalent combination of education and experience sufficient to successfully perform the key responsibilities of this job, required
• • English fluency (ability to read, write, speak), required
• • Travel of up to 25% is required for this position. Exact amounts of travel will vary, pending client needs
• • To qualify, applicants must be legally authorized to work in the United States or Canada, and should not require, now or in the future, sponsorship for employment visa status
• • Undergraduate degree in clinical, science, or health-related field, preferred
• • Licensed healthcare professional (i.e., registered nurse), preferred
• • Minimum 1-2 years of experience leading Oncology cellular therapy clinical trials, strongly preferred